Table 1 Baseline characteristics of patients with CT scan
From: Hypo-attenuated leaflet thickening in surgically-implanted mitral bioprosthesis
Variables | N = 53 |
|---|---|
Age (years) | 71.6 ± 8.9 |
Male | 26 (49.0) |
Diabetes | 12 (22.6) |
COPD | 0 (0.0) |
Creatinine (mg/dL) | 1.02 ± 0.95 |
Chronic kidney disease | 0 (0.0) |
NYHA functional class I or II | 42 (79.2) |
NYHA functional class III or IV | 11 (20.8) |
Previous PMI | 0 (0.0) |
Previous CABG | 1 (1.9) |
Previous valve surgery | 4 (7.5) |
Operative variables | |
Emergency | 3 (5.7) |
Urgent | 0 (0.0) |
Elective | 50 (94.3) |
Concomitant operations | |
MAZE | 34 (64.2) |
CABG | 9 (17.0) |
AVR | 14 (26.4) |
TAP | 29 (54.7) |
Cross-clamp time (minutes) | 105.7 ± 31.2 |
Perfusion time (minutes) | 154.4 ± 37.5 |
Operation time (minutes) | 271.5 ± 54.0 |
Valve size (mm) | |
25 | 15 (28.3) |
27 | 27 (50.9) |
29 | 10 (18.9) |
31 | 1 (1.9) |
Valve type | |
Carpentier-Edwards Pericardial Bioprosthesis | 12 (22.6) |
Magna Ease | 16 (30.2) |
Mosaic | 15 (28.3) |
St. Jude Medical Epic | 10 (18.9) |
Stroke within 30 days of operation | 2 (3.8) |